
Please try another search
By Davit Kirakosyan
Morgan Stanley cut its price targets on Visa (NYSE:V) to $282 from $291 and on Mastercard Inc (NYSE:MA) to $441 from $457, based on FX headwinds due to the large international exposure. The analysts reiterated their Overweight Rating on both companies.
BofA Securities lowered its price target on Amazon (NASDAQ:AMZN) to $157 from $170, while maintaining a Buy rating. The analysts lowered their forward estimates, reflecting higher macroeconomic uncertainty as well as U.S. dollar appreciation since mid-August.
Deutsche Bank lowered the price target on Rite Aid Corporation (NYSE:RAD) to $3.00 from $4.00, while maintaining a Sell rating. This was followed by the company’s Q2 earnings announcement, which showed the company’s core pharmacy business continues to erode.
Goldman Sachs raised the price target on Regeneron Pharma (NASDAQ:REGN) to $970.00 from $796.00, while reiterating its Buy rating.
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.